Friday, 6 December 2024

Breaking News on Dimentia


New Atlas reports:

Filament Limited, an Australian biotech company focused on developing next-gen anti-inflammatory drugs, has announced its breakthrough dementia treatment. ALPHA-003 is designed to preserve the integrity of vital brain cell structures and protect them against destruction caused by brain inflammation.

____________________

1 comment:

Blogs will be forwarded to national leaders, business leaders and others who might need to see such blogs.